Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy.

Authors:
Zhao P; Xie L; Yu L; Wang P.

Journal:
Genes Dis

Publication Year: 2023

DOI:
10.1016/j.gendis.2022.12.008

PMCID:
PMC10425755

PMID:
37588232

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Genes Dis

Abbreviation: Genes Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fib…
Xu Z; Davies ER; Yao L and 11 more (2024) - Transparency Score: 4/6
Advances in oral mesenchymal stem cell-derived extracellular vesicles in health and disease.
Luo H; Birjandi AA; Ren F and 4 more (2023) - Transparency Score: 3/6
A <i>BBS4</i> mutation causes autosomal dominant polycystic liver disease.
Cui Y; Xu W; Liu J and 6 more (2023) - Transparency Score: 3/6
An analysis of the transcriptional landscape in hypoxia-treated primary nucleus pulposus cells.
Peng Z; Wang Z; Guo S and 7 more (2023) - Transparency Score: 3/6
A novel preimplantation genetic testing strategy for a subtelomeric genetic disorder: A case study.
Chen S; Wang L; Chen L and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interests The authors declare no conflict of interests."

Evidence found in paper:

"Funding This work was supported by the 10.13039/501100012166National Key Research and Development Program of China (No. 2020YFA0803201), the 10.13039/501100001809National Natural Science Foundation of China (No. 31830053, 31920103007, 22207084), and the Fundamental Research Funds for the 10.13039/100007231Cornell University (No. 22120220463)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025